gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
CD3 is on T cells; elranatamab binds CD3 to activate and recruit T cells, which kill BCMA-positive myeloma cells via perforin/granzyme. CD3+ cells are not targeted for killing.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06711705
disease_id_num_tar_ref
248
drug_id_num_tar_ref
704